Patient & Survivor Care
Guidelines
ASCO/ASH Clinical Practice Update: Erythropoiesis-stimulating agents
ESAs may be offered to patients with chemotherapy-associated anemia whose cancer treatment is not curative in intent, but should not be offered to...
News
CDC clarifies opioid prescribing guidelines in cancer, sickle cell disease
The Centers for Disease Control and Prevention clarified its guidelines on opioid prescribing after concerns surfaced that insurers were...
Conference Coverage
In endometrial cancer and SUI, concomitant surgery improves outcomes
TUCSON, ARIZ. – The biggest trick may be incorporating concomitant surgeries into the surgical work flow.
Conference Coverage
Genetic variant increases stroke risk in childhood cancer survivors
ATLANTA - Dr. Yadav Sapkota of St. Jude Children's Research Hospital discusses the identification of a genetic variant that is strongly associated...
Hard Questions
Doctor, will you please lie to me?
Looking for hope in the face of terrible news is a common reaction. It’s natural. We tend to be optimists, and we look for a silver lining. We...
From the Journals
Worse survival seen among black patients with MCL
There was a survival gap between black and white patients, even though black patients with mantle cell lymphoma were more likely to be treated in...
Conference Coverage
WISP: Early data provide further support for ISDO in women at high OC risk
HONOLULU – RRSO or ISDO each lead to significant reductions in cancer distress, but regret is greater with RRSO,...
Conference Coverage
Preliminary data show similar declines in worry, low regret with RRSO and RRS/RRO
HONOLULU – Early findings from the TUBA trial suggest similar declines in worry among women with BRCA1/2 mutations who undergo risk-reducing...
News
‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patients
However, there was no difference versus controls in goal-concordant care or peacefulness at end of life.
Conference Coverage
MI, strokes spike during 30 days after cancer diagnosis
HONOLULU – During the first 30 days after a cancer diagnosis, the incidence of an MI or stroke jumped nearly 500%.
Conference Coverage
KD025 produces durable responses in patients with cGVHD
HOUSTON – Many responses have lasted 20 weeks or more, and durability data are still maturing.